{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T00:37:52Z","timestamp":1773275872906,"version":"3.50.1"},"reference-count":55,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2006,12,1]],"date-time":"2006-12-01T00:00:00Z","timestamp":1164931200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Contemporary Clinical Trials"],"published-print":{"date-parts":[[2006,12]]},"DOI":"10.1016\/j.cct.2006.07.002","type":"journal-article","created":{"date-parts":[[2006,7,22]],"date-time":"2006-07-22T11:17:05Z","timestamp":1153567025000},"page":"518-530","source":"Crossref","is-referenced-by-count":15,"title":["Heart positive: Design of a randomized controlled clinical trial of intensive lifestyle intervention, niacin and fenofibrate for HIV lipodystrophy\/dyslipidemia"],"prefix":"10.1016","volume":"27","author":[{"given":"Susan L.","family":"Samson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henry J.","family":"Pownall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lynne W.","family":"Scott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christie M.","family":"Ballantyne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E. O'Brian","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajagopal V.","family":"Sekhar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashok","family":"Balasubramanyam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cct.2006.07.002_bib1","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/00041433-200106000-00011","article-title":"Antiretroviral therapy-associated hyperlipidaemia in HIV disease","volume":"12","author":"Mooser","year":"2001","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.cct.2006.07.002_bib2","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1111\/j.1749-6632.2001.tb03913.x","article-title":"Cardiovascular disease risk factors in HIV-infected patients in the HAART era","volume":"946","author":"Galli","year":"2001","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.cct.2006.07.002_bib3","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S1043-2760(01)00472-6","article-title":"Insulin resistance in the HIV-lipodystrophy syndrome","volume":"12","author":"Grinspoon","year":"2001","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.cct.2006.07.002_bib4","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.1001\/jama.1986.03380200073024","article-title":"Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study","volume":"256","author":"Castelli","year":"1986","journal-title":"JAMA"},{"key":"10.1016\/j.cct.2006.07.002_bib5","doi-asserted-by":"crossref","first-page":"3046","DOI":"10.1161\/hc5001.100624","article-title":"Influence of low high-density lipoprotein cholesterol and elevated triglyceride on coronary heart disease events and response to simvastatin therapy in 4S","volume":"104","author":"Ballantyne","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.cct.2006.07.002_bib6","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1097\/00041433-200108000-00009","article-title":"Diabetes and other coronary heart disease risk equivalents","volume":"12","author":"James","year":"2001","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.cct.2006.07.002_bib7","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1086\/317541","article-title":"Metabolic abnormalities and cardiovascular disease risk factors in adults with human immunodeficiency virus infection and lipodystrophy","volume":"32","author":"Hadigan","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cct.2006.07.002_bib8","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1185\/030079905X65529","article-title":"Dyslipidemia and cardiovascular risk in HIV infection","volume":"21","author":"Kulasekaram","year":"2005","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.cct.2006.07.002_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.atherosclerosis.2005.09.025","article-title":"Impact of HIV and highly active antiretroviral therapy on leukocyte adhesion molecules, arterial inflammation, dyslipidemia, and atherosclerosis","volume":"185","author":"Fisher","year":"2005","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.cct.2006.07.002_bib10","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s11883-004-0029-2","article-title":"Cardiovascular implications of HIV-associated dyslipidemic lipodystrophy","volume":"6","author":"Sekhar","year":"2004","journal-title":"Curr Atheroscler Rep"},{"key":"10.1016\/j.cct.2006.07.002_bib11","first-page":"E332","article-title":"Metabolic basis of HIV lipodystrophy syndrome","volume":"283","author":"Sekhar","year":"2002","journal-title":"Am J Physiol"},{"key":"10.1016\/j.cct.2006.07.002_bib12","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1093\/ajcn\/81.6.1405","article-title":"Severely dysregulated disposal of postprandial triacylglycerols exacerbates hypertriglycerolemia in HIV lipodystrophy syndrome","volume":"81","author":"Sekhar","year":"2005","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.cct.2006.07.002_bib13","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1042\/bj2510809","article-title":"Effects of oleic acid on the biosynthesis of lipoprotein apoproteins and distribution into the very-low-density lipoprotein by the isolated perfused rat liver","volume":"251","author":"Salam","year":"1988","journal-title":"Biochem J"},{"key":"10.1016\/j.cct.2006.07.002_bib14","doi-asserted-by":"crossref","first-page":"7","DOI":"10.2337\/diabetes.51.1.7","article-title":"Dysregulation of fatty acid metabolism in the etiology of type 2 diabetes","volume":"51","author":"McGarry","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.cct.2006.07.002_bib15","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/00041433-200402000-00011","article-title":"Pathophysiology of dyslipidemia and increased cardiovascular risk in HIV lipodystrophy: a model of systemic steatosis","volume":"15","author":"Balasubramanyam","year":"2004","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.cct.2006.07.002_bib16","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1097\/00002030-200404300-00011","article-title":"Reversibility of lipoatrophy in HIV-infected patients 2-years after switching from a thymidine analogue to abacavir: the MITOX extension study","volume":"18","author":"Martin","year":"2004","journal-title":"AIDS"},{"key":"10.1016\/j.cct.2006.07.002_bib17","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/00126334-200305010-00005","article-title":"Randomized, controlled, 48-week study of switching stavudine and\/or protease inhibitors to combivir\/abacavir to prevent or reverse lipoatrophy in HIV-infected patients","volume":"33","author":"John","year":"2003","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.cct.2006.07.002_bib18","first-page":"263","article-title":"Increased adipocyte apoptosis in lipoatrophy improves within 48\u00a0weeks of switching patient therapy from stavudine to abacavir or sidovudine","volume":"38","author":"Cherry","year":"2005","journal-title":"J Aquir Immune Defic Syndr"},{"key":"10.1016\/j.cct.2006.07.002_bib19","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1592\/phco.20.13.1066.35033","article-title":"Safety and efficacy of HMG-CoA reductase inhibitors for treatment of hyperlipidemia in patients with HIV infection","volume":"20","author":"Penzak","year":"2001","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.cct.2006.07.002_bib20","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1097\/00002030-200203080-00008","article-title":"Pharmacokinetic interactions between protease inhibitors and statins in HIV seronegative volunteers: ACTG Study A5047","volume":"16","author":"Fichtenbaum","year":"2002","journal-title":"AIDS"},{"key":"10.1016\/j.cct.2006.07.002_bib21","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0140-6736(04)15489-5","article-title":"No effect of rosiglitazone for treatment of HIV-1 lipoatrophy: randomized, double-blind, placebo-controlled trial","volume":"363","author":"Carr","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.cct.2006.07.002_bib22","doi-asserted-by":"crossref","first-page":"840","DOI":"10.7326\/0003-4819-135-9-200111060-00017","article-title":"HIV-1 protease inhibitors may interfere with the ubiquitous intracellular proteases","volume":"136","author":"Visnegarwala","year":"2001","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cct.2006.07.002_bib23","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1001\/jama.284.4.472","article-title":"Metformin in the treatment of HIV lipodystrophy syndrome: a randomized controlled trial","volume":"284","author":"Hadigan","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.cct.2006.07.002_bib24","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/00001432-200502000-00004","article-title":"Use of recombinant human growth hormone in HIV-associated lipodystrophy","volume":"18","author":"Burgess","year":"2005","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.cct.2006.07.002_bib25","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1086\/422144","article-title":"Niacin in HIV-infected individuals with hyperlipidemia receiving potent antiretroviral therapy","volume":"39","author":"Gerber","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cct.2006.07.002_bib26","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1097\/00002030-200209060-00011","article-title":"High-density lipoprotein cholesterol is low in HIV-infected patients with lipodystrophic fat expansion: implications for pathogenesis of fat redistribution","volume":"16","author":"Fessel","year":"2002","journal-title":"AIDS"},{"key":"10.1016\/j.cct.2006.07.002_bib27","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1097\/00002030-200211080-00012","article-title":"A randomized, double-blind study of gemfibrozil (GF) for the treatment of protease inhibitor-associated hypertriglyceridemia","volume":"16","author":"Miller","year":"2002","journal-title":"AIDS"},{"key":"10.1016\/j.cct.2006.07.002_bib28","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1097\/00002030-200304110-00010","article-title":"Statins and fibrates for the treatment of hyperlipidaemia in HIV-infected patients receiving HAART","volume":"17","author":"Calza","year":"2003","journal-title":"AIDS"},{"key":"10.1016\/j.cct.2006.07.002_bib29","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1007\/s11745-000-0584-0","article-title":"Preferential loss of visceral fat following aerobic exercise, measured by magnetic resonance imaging","volume":"35","author":"Thomas","year":"2000","journal-title":"Lipids"},{"key":"10.1016\/j.cct.2006.07.002_bib30","doi-asserted-by":"crossref","first-page":"92","DOI":"10.7326\/0003-4819-133-2-200007180-00008","article-title":"Reduction in obesity and related comorbid conditions after diet-induced weight loss or exercise-induced weight loss in men","volume":"133","author":"Ross","year":"2000","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cct.2006.07.002_bib31","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1080\/00325481.1995.11946037","article-title":"Niacin for lipid disorders","volume":"98","author":"Brown","year":"1995","journal-title":"Postgrad Med"},{"key":"10.1016\/j.cct.2006.07.002_bib32","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1006\/phrs.2001.0871","article-title":"PPARs, metabolic disease and atherosclerosis","volume":"44","author":"Fruchart","year":"2001","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.cct.2006.07.002_bib33","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1161\/01.ATV.10.4.520","article-title":"Inheritance of low density lipoprotein subclass patterns in familial combined hyperlipidemia","volume":"10","author":"Austin","year":"1990","journal-title":"Arteriosclerosis"},{"key":"10.1016\/j.cct.2006.07.002_bib34","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/0005-2760(81)90253-8","article-title":"Characterization of human high-density lipoproteins by gradient gel electrophoresis","volume":"665","author":"Blanche","year":"1981","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.cct.2006.07.002_bib35","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1093\/clinchem\/32.2.283","article-title":"Improved estimation of cholesteryl ester transfer\/exchange activity in serum or plasma","volume":"32","author":"Groener","year":"1986","journal-title":"Clin Chem"},{"key":"10.1016\/j.cct.2006.07.002_bib36","series-title":"Human Body Composition","article-title":"Imaging techniques applied to the measurement of human body composition","author":"Despres","year":"1996"},{"key":"10.1016\/j.cct.2006.07.002_bib37","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.2337\/diacare.22.9.1462","article-title":"Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp","volume":"22","author":"Matsuda","year":"1999","journal-title":"Diabetes Care"},{"key":"10.1016\/j.cct.2006.07.002_bib38","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/S0002-8223(21)07997-9","article-title":"Sources of data for developing and maintaining a nutrient database","volume":"88","author":"Schakel","year":"1988","journal-title":"J Am Diet Assoc"},{"key":"10.1016\/j.cct.2006.07.002_bib39","author":"U.S. Department of Agriculture"},{"key":"10.1016\/j.cct.2006.07.002_bib40","series-title":"The new Living Heart Diet","author":"DeBakey","year":"1996"},{"key":"10.1016\/j.cct.2006.07.002_bib41","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","volume":"285","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.cct.2006.07.002_bib42","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1161\/01.CIR.102.18.2284","article-title":"AHA Dietary Guidelines: revision 2000: a statement for healthcare professionals from the nutrition committee of the American Heart Association","volume":"102","author":"Krauss","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.cct.2006.07.002_bib43","doi-asserted-by":"crossref","first-page":"S50","DOI":"10.2337\/diacare.25.2007.S50","article-title":"Evidence-based nutrition principles and recommendations for the treatment and prevention of diabetes and related complications","volume":"25","author":"American Diabetes Association","year":"2002","journal-title":"Diabetes Care"},{"key":"10.1016\/j.cct.2006.07.002_bib44","series-title":"Guidelines for exercise testing and prescription","author":"American College of Sports Medicine (ACSM)","year":"2001"},{"key":"10.1016\/j.cct.2006.07.002_bib45","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1249\/00005768-199409000-00004","article-title":"Prescribing exercise intensity for healthy adults using perceived exertion","volume":"26","author":"Dishman","year":"1994","journal-title":"Med Sci Sports Exerc"},{"key":"10.1016\/j.cct.2006.07.002_bib46","doi-asserted-by":"crossref","first-page":"389","DOI":"10.2165\/00007256-199928060-00002","article-title":"HIV and aerobic exercise \u2014 current recommendations","volume":"28","author":"Stringer","year":"1999","journal-title":"Sports Med"},{"key":"10.1016\/j.cct.2006.07.002_bib47","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1152\/jappl.2001.90.1.133","article-title":"Resistance exercise training reduces hypertriglyceridemia in HIV-infected men treated with antiviral therapy","volume":"90","author":"Yarasheski","year":"2001","journal-title":"J Appl Physiol"},{"key":"10.1016\/j.cct.2006.07.002_bib48","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1056\/NEJMoa011090","article-title":"Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease","volume":"345","author":"Brown","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cct.2006.07.002_bib49","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1136\/bjo.79.1.54","article-title":"Adverse ocular effects associated with niacin therapy","volume":"79","author":"Fraunfelder","year":"1995","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.cct.2006.07.002_bib50","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1097\/00002030-200110190-00021","article-title":"Short-term exercise training improves body composition and hyperlipidemia in HIV-positive individuals with lipodystrophy","volume":"15","author":"Jones","year":"2001","journal-title":"AIDS"},{"key":"10.1016\/j.cct.2006.07.002_bib51","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1001\/jama.1994.03510330050033","article-title":"A comparison of the efficacy and toxic effects of sustained- vs. immediate-release niacin in hypercholesterolemic patients","volume":"271","author":"McKenney","year":"1994","journal-title":"JAMA"},{"key":"10.1016\/j.cct.2006.07.002_bib52","doi-asserted-by":"crossref","first-page":"615","DOI":"10.2165\/00003495-199754040-00007","article-title":"Micronised fenofibrate: a review of its pharmacodynamic properties and clinical efficacy in the management of dyslipidemia","volume":"54","author":"Adkins","year":"1997","journal-title":"Drugs"},{"key":"10.1016\/j.cct.2006.07.002_bib53","doi-asserted-by":"crossref","first-page":"348","DOI":"10.7326\/0003-4819-133-5-200009050-00010","article-title":"Effects of testosterone and progressive resistance training in eugonadal men with AIDS wasting","volume":"133","author":"Grinspoon","year":"2000","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cct.2006.07.002_bib54","series-title":"Applied regression analysis and other multivariable methods","author":"Kleinbaum","year":"1988"},{"key":"10.1016\/j.cct.2006.07.002_bib55","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1086\/322680","article-title":"Modifiable dietary habits and their relation to metabolic abnormalities in men and women with human immunodeficiency virus infection and fat redistribution","volume":"33","author":"Hadigan","year":"2001","journal-title":"Clin Infect Dis"}],"container-title":["Contemporary Clinical Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551714406000929?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551714406000929?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,8]],"date-time":"2023-05-08T05:36:18Z","timestamp":1683524178000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1551714406000929"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,12]]},"references-count":55,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2006,12]]}},"alternative-id":["S1551714406000929"],"URL":"https:\/\/doi.org\/10.1016\/j.cct.2006.07.002","relation":{},"ISSN":["1551-7144"],"issn-type":[{"value":"1551-7144","type":"print"}],"subject":[],"published":{"date-parts":[[2006,12]]}}}